A novel immune-associated prognostic signature based on the immune cell infiltration analysis for hepatocellular carcinoma

被引:20
作者
Lin, Xinrong [1 ]
Tian, Chuan [1 ]
Pan, Fan [1 ]
Wang, Rui [1 ]
机构
[1] Nanjing Univ, Affiliated Jinling Hosp, Med Sch, Dept Med Oncol, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
HCC; tumor-infiltrating immune cells; immune-related genes; risk score; bioinformatics;
D O I
10.1515/oncologie-2023-0360
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Immune-related genes (IRGs) in hepatocellular carcinoma (HCC) are significantly associated with both tumor-infiltrating immune cells (TICs) and disease prognosis. Therefore, exploring the correlation between IRGs with HCC and its related mechanism will provide new evidence for the diagnosis and treatment of HCC.Methods: The current paper analyzed the TICs in 374 HCC samples retrieved from the TCGA-LIHC dataset using ssGSEA and divided them according to the level of immune cell. A total of 177 differentially expressed genes (DEGs) were analyzed by protein-protein interaction (PPI) networks and univariate and multivariate Cox regression analyses.Results: Four IRGs (C7, CTSV, MMP1, and VCAN) were found to be indicators of the immune prognosis for HCC according to the PPI network and Cox regression analyses of 177 DEGs, which was independently validated using an external dataset. A prognosis risk model was constructed for factors dependent on the four IRGs. Prognostic risk was associated with the subtype of infiltrating immune cells.Conclusions: Four effective IRGs were identified as novel independent prognostic factors that were correlated with tumor immune infiltration in HCC. This signature may guide the choice of immunotherapy for HCC.
引用
收藏
页码:91 / 103
页数:13
相关论文
共 23 条
[1]   RETRACTED: Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis (Retracted Article) [J].
Cao, Ming-De ;
Song, Yan-Cheng ;
Yang, Zhong-Meng ;
Wang, Da-Wei ;
Lin, Yi-Ming ;
Lu, Hua-Ding .
ONCOTARGETS AND THERAPY, 2020, 13 :8095-8107
[2]   Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients [J].
Chen, Dongjie ;
Liu, Jixing ;
Zang, Longjun ;
Xiao, Tijun ;
Zhang, Xianlin ;
Li, Zheng ;
Zhu, Hongwei ;
Gao, Wenzhe ;
Yu, Xiao .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (01) :360-373
[3]   Hepatocellular Carcinoma New Developments [J].
Ganesan, Previn ;
Kulik, Laura M. .
CLINICS IN LIVER DISEASE, 2023, 27 (01) :85-102
[4]   The Gene Ontology (GO) project in 2006 [J].
Harris, Midori A. ;
Clark, Jennifer I. ;
Ireland, Amelia ;
Lomax, Jane ;
Ashburner, Michael ;
Collins, Russell ;
Eilbeck, Karen ;
Lewis, Suzanna ;
Mungall, Chris ;
Richter, John ;
Rubin, Gerald M. ;
Shu, ShengQiang ;
Blake, Judith A. ;
Bult, Carol J. ;
Diehl, Alexander D. ;
Dolan, Mary E. ;
Drabkin, Harold J. ;
Eppig, Janan T. ;
Hill, David P. ;
Ni, Li ;
Ringwald, Martin ;
Balakrishnan, Rama ;
Binkley, Gail ;
Cherry, J. Michael ;
Christie, Karen R. ;
Costanzo, Maria C. ;
Dong, Qing ;
Engel, Stacia R. ;
Fisk, Dianna G. ;
Hirschman, Jodi E. ;
Hitz, Benjamin C. ;
Hong, Eurie L. ;
Lane, Christopher ;
Miyasato, Stuart ;
Nash, Robert ;
Sethuraman, Anand ;
Skrzypek, Marek ;
Theesfeld, Chandra L. ;
Weng, Shuai ;
Botstein, David ;
Dolinski, Kara ;
Oughtred, Rose ;
Berardini, Tanya ;
Mundodi, Suparna ;
Rhee, Seung Y. ;
Apweiler, Rolf ;
Barrell, Daniel ;
Camon, Evelyn ;
Dimmer, Emily ;
Mulder, Nicola .
NUCLEIC ACIDS RESEARCH, 2006, 34 :D322-D326
[5]   An Immunogram for an Individualized Assessment of the Antitumor Immune Response in Patients With Hepatocellular Carcinoma [J].
Hu, Ying ;
Sun, Huaibo ;
Zhang, Henghui ;
Wang, Xianbo .
FRONTIERS IN ONCOLOGY, 2020, 10
[6]   Peripheral cytokine levels as predictive biomarkers of benefit from immune checkpoint inhibitors in cancer therapy [J].
Ji, Shoujian ;
Chen, Huan ;
Yang, Keyan ;
Zhang, Guanxiong ;
Mao, Beibei ;
Hu, Ying ;
Zhang, Henghui ;
Xu, Jianming .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
[7]   Novel nomograms based on immune and stromal scores for predicting the disease-free and overall survival of patients with hepatocellular carcinoma undergoing radical surgery [J].
Jiang, Shitao ;
Zhang, Junwei ;
Bian, Jin ;
Zhang, Lei ;
Xu, Yiyao ;
Zhao, Haitao ;
Sang, Xinting ;
Lu, Xin .
JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (08) :1569-1579
[8]   KEGG: new perspectives on genomes, pathways, diseases and drugs [J].
Kanehisa, Minoru ;
Furumichi, Miho ;
Tanabe, Mao ;
Sato, Yoko ;
Morishima, Kanae .
NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) :D353-D361
[9]   Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis [J].
Kawamura, Yusuke ;
Kobayashi, Masahiro ;
Shindoh, Junichi ;
Kobayashi, Yuta ;
Kasuya, Kayoko ;
Sano, Tomoya ;
Fujiyama, Shunichiro ;
Hosaka, Tetsuya ;
Saitoh, Satoshi ;
Sezaki, Hitomi ;
Akuta, Norio ;
Suzuki, Fumitaka ;
Suzuki, Yoshiyuki ;
Ikeda, Kenji ;
Arase, Yasuji ;
Hashimoto, Masaji ;
Kumada, Hiromitsu .
LIVER CANCER, 2020, 9 (03) :275-292
[10]   Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma [J].
Li, Sheng-chao ;
Xu, Zhuo ;
Deng, Yan-li ;
Wang, Ya-ni ;
Jia, Yu-ming .
MEDICINE, 2020, 99 (27) :E20919